Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | La, S | - |
dc.contributor.author | Cho, JH | - |
dc.contributor.author | Kim, JH | - |
dc.contributor.author | Kim, KR | - |
dc.date.available | 2021-02-23T05:15:04Z | - |
dc.date.issued | 2003-06 | - |
dc.identifier.issn | 0003-2670 | - |
dc.identifier.issn | 1873-4324 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/17419 | - |
dc.description.abstract | Metabolic profiling analysis by capillary electrophoresis (CE) was combined with pattern recognition methods to see some correlation between urinary nucleoside levels and thyroid cancer. A total of 15 nucleosides were identified in urines from 12 female thyroid cancer patients and 12 healthy females studied. From the scatter plot evaluation, inosine showed the highest estimated diagnostic power with ca. 97.725% confidence level, followed by N-2-methylguanosine. Star symbol graphs showed differences in levels of both minor and major nucleosides between cancer and normal groups more efficiently, compared with histogram. The stepwise discriminant analysis (SDA) selected N-2-methylguanosine, N-2,N-2-dimethylguanosine and 1-methylguanosine as the most discriminating variables between thyroid cancer and normal groups. The canonical discriminant analysis (CDA) correctly classified all urine specimens studied into two separate clusters of cancer and normal groups in a canonical plot. The principal component analysis (PCA) distinguished cancer patients from normal controls in a principal component plot. The cluster analysis (CA) yielded a dendrogram displaying group separation without any single wrong linkage. (C) 2003 Elsevier Science B.V. All rights reserved. | - |
dc.format.extent | 12 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients | - |
dc.type | Article | - |
dc.publisher.location | 네델란드 | - |
dc.identifier.doi | 10.1016/S0003-2670(03)00473-2 | - |
dc.identifier.scopusid | 2-s2.0-0037505128 | - |
dc.identifier.wosid | 000183732100003 | - |
dc.identifier.bibliographicCitation | ANALYTICA CHIMICA ACTA, v.486, no.2, pp 171 - 182 | - |
dc.citation.title | ANALYTICA CHIMICA ACTA | - |
dc.citation.volume | 486 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 171 | - |
dc.citation.endPage | 182 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.subject.keywordPlus | PLACENTAL ALKALINE-PHOSPHATASE | - |
dc.subject.keywordPlus | TISSUE POLYPEPTIDE ANTIGEN | - |
dc.subject.keywordPlus | CARCINOEMBRYONIC ANTIGEN | - |
dc.subject.keywordPlus | BIOLOGICAL MARKERS | - |
dc.subject.keywordPlus | ORGANIC-ACIDS | - |
dc.subject.keywordPlus | UTERINE MYOMA | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | PSEUDOURIDINE | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | EXCRETION | - |
dc.subject.keywordAuthor | urinary nucleosides | - |
dc.subject.keywordAuthor | capillary electrophoresis | - |
dc.subject.keywordAuthor | thyroid cancer | - |
dc.subject.keywordAuthor | pattern recognition | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.